On September 3, 2019 Oramed Pharmaceuticals Inc. (NASDAQ: ORMP) (TASE: ORMP) (www.oramed.com), a clinical-stage pharmaceutical company focused on the development of oral drug delivery systems, reported that the company will present at three conferences in New York in the first half of September 2019 (Press release, Oramed Pharmaceuticals, SEP 3, 2019, View Source [SID1234539226]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

RHK Capital 4th Annual Disruptive Growth Conference
Date: September 4, 2019
Time: 2:00 p.m.
Location: 599 Lexington Avenue, New York, NY
Presenter: Estee Yaari, Director, Corporate Communications

H. C. Wainwright 21st Annual Global Investment Conference
Date: September 9, 2019
Time: 9:10 a.m.
Location: Lotte New York Palace Hotel, New York
Presenter: Nadav Kidron, CEO

The Future of Healthcare Panel Discussion
Date: September 12, 2019
Time: 6:00 p.m.
Location: SOSA NYC
Presenter: Nadav Kidron, CEO